Sustained activation of STAT-3 after AMI has been reported to contribute to inflammatory processes and cardiac remodeling, and this activation is probably downstream of interleukin-6 via the gp-130 receptor48 whereas inhibition of JAK2/STAT-3 pathway attenuated cardiac hypertrophy.49 The gene discussed is IL6; the disease is cardiac hypertrophy.